Effectiveness and safety of mizoribine for the treatment of IgG4-related disease: a retrospective cohort study.

Sho FukuiSatoshi KawaaiTakehiro NakaiMasei SudaYukihiko IkedaAtsushi NomuraHiromichi TamakiMitsumasa KishimotoSachiko OhdeMasato Okada

Published in: Rheumatology (Oxford, England) (2021)

MZR decreased disease exacerbation among IgG4RD patients with multi-organ involvement and showed a steroid-sparing effect. MZR could be a treatment option for IgG4RD.

Keyphrases

acute respiratory distress syndrome